CPR Opioid Overdose Response and Naloxone 1 — Questions and Answers

Question 1: What are the three classic signs of opioid overdose, known as the 'opioid overdose triad'?

Fever, vomiting, and rapid heart rate
Pinpoint pupils, unconsciousness, and respiratory depression (slow or absent breathing) (Correct answer)
Dilated pupils, agitation, and tachycardia
Chest pain, diaphoresis, and arm weakness

Correct answer: Pinpoint pupils, unconsciousness, and respiratory depression (slow or absent breathing)

The opioid overdose triad: miosis (pinpoint pupils), unconsciousness/unresponsiveness, and respiratory depression—recognize these to respond quickly.

The opioid overdose triad consists of: (1) Miosis (pinpoint pupils)—opioids cause intense constriction of the pupils, which remains even in bright light (unlike normal physiologic miosis), (2) Unconsciousness—ranging from deep sedation to complete unresponsiveness, and (3) Respiratory depression—slow, shallow breathing (bradypnea), irregular respirations, or complete apnea. Additional signs include cyanosis (blue lips/fingertips from hypoxia), gurgling or snoring respirations, limp muscles, and pale, clammy skin. Note that some synthetic opioids (e.g., certain fentanyl analogs) may cause muscle rigidity ('wooden chest syndrome'). Recognizing this triad is the first step in life-saving intervention.

Question 2: How does naloxone (Narcan) reverse opioid overdose?

It metabolizes opioids in the bloodstream and removes them
It competitively binds to opioid receptors, displacing opioids and reversing their effects (Correct answer)
It stimulates the heart to beat faster
It constricts blood vessels to increase blood pressure

Correct answer: It competitively binds to opioid receptors, displacing opioids and reversing their effects

Naloxone is an opioid receptor antagonist that displaces opioids from receptors in the brain and reverses respiratory depression, sedation, and miosis.

Naloxone is a competitive opioid receptor antagonist—it has high affinity for opioid receptors (particularly mu-opioid receptors) but no intrinsic opioid activity. When administered, naloxone rapidly displaces bound opioids from receptors throughout the body, including in the brain stem respiratory centers, reversing respiratory depression, sedation, and miosis within 2-5 minutes of IV/IM administration. The reversal effect lasts approximately 30-90 minutes (depending on dose and route), which is shorter than most opioids' duration of action—meaning overdose can recur when naloxone wears off ('renarcotization'). Naloxone does not affect non-opioid overdose (alcohol, benzodiazepines, stimulants) and may precipitate acute withdrawal in opioid-dependent individuals.

Question 3: What is the recommended initial adult dose of intranasal naloxone for opioid overdose reversal?

0.4 mg (1 mL of 0.4 mg/mL solution)
4 mg intranasally (one full actuation of the 4 mg/0.1 mL device) (Correct answer)
10 mg intranasally
0.1 mg intranasally

Correct answer: 4 mg intranasally (one full actuation of the 4 mg/0.1 mL device)

The FDA-approved Narcan nasal spray delivers 4 mg per actuation and is the standard first-line dose for opioid overdose reversal in community settings.

The standard naloxone nasal spray (Narcan) approved for community use delivers 4 mg of naloxone per actuation in a 0.1 mL concentrated solution. This higher dose (compared to older 2 mg preparations) was developed to address the higher potency of illicitly manufactured fentanyl and other synthetic opioids. In clinical settings, IV naloxone is typically dosed at 0.4-2 mg IV/IO, though the dose for respiratory depression is often titrated to restore adequate breathing without precipitating full withdrawal (0.04-0.4 mg IV titrated slowly). For bystanders and community responders, the 4 mg nasal spray provides a simple, no-calculation single-dose approach. More potent opioids like carfentanil may require multiple doses.

Question 4: After administering naloxone to a suspected opioid overdose victim who is not responding, what is the appropriate next action?

Wait 30 minutes for the drug to work before doing anything else
If no response in 2-3 minutes, administer a second dose of naloxone and continue rescue breathing (Correct answer)
Stop all resuscitation efforts
Administer a stimulant to increase heart rate

Correct answer: If no response in 2-3 minutes, administer a second dose of naloxone and continue rescue breathing

If there is no response after 2-3 minutes, a second dose should be given; rescue breathing should continue throughout as naloxone may take time to work.

If the first dose of naloxone produces no response within 2-3 minutes (no increase in breathing, no movement, no change in responsiveness), a second dose should be administered in the same manner. Multiple doses may be required, particularly with synthetic opioids like fentanyl, which may require 2-3 doses or higher total naloxone amounts due to their high receptor affinity. Rescue breathing (mouth-to-mouth or with a mask) should be performed throughout if the person is not breathing adequately—oxygenation is critical during the period before naloxone takes effect. Call 911 immediately and continue support until EMS arrives. Do not assume the person is not using opioids if naloxone doesn't work—consider other causes.

Question 5: What is 'renarcotization' in the context of naloxone administration?

The process of re-administering opioids after treatment
The return of overdose symptoms when naloxone wears off before the opioid has been metabolized, requiring repeat doses or continued monitoring (Correct answer)
An allergic reaction to naloxone
A withdrawal syndrome caused by naloxone

Correct answer: The return of overdose symptoms when naloxone wears off before the opioid has been metabolized, requiring repeat doses or continued monitoring

Renarcotization occurs when naloxone's effect wears off (30-90 min) before the opioid is fully metabolized, causing overdose symptoms to return.

Renarcotization (re-narcotization or recurrence of opioid toxicity) occurs because naloxone has a shorter duration of action (approximately 30-90 minutes, depending on dose and route) than most opioids. Extended-release or long-acting opioids (methadone, extended-release oxycodone, buprenorphine) and large overdose quantities are especially likely to cause renarcotization. This is why all naloxone-treated patients require medical evaluation and monitoring in a healthcare facility—it is not safe to assume an overdose victim who responds to naloxone is 'cured.' EMS and emergency physicians may give continuous naloxone infusions or repeated doses. In out-of-hospital settings, always call 911 even if the person appears to recover after naloxone.

Question 6: Which of the following opioid reversal routes is preferred for rapid emergency use by bystanders?

Intravenous (IV)
Intramuscular (IM) or intranasal (IN) (Correct answer)
Subcutaneous (SQ)
Oral (PO)

Correct answer: Intramuscular (IM) or intranasal (IN)

IM and intranasal routes are preferred for bystanders and first responders because no needles or IV access are required, allowing rapid administration.

For lay bystanders and first responders without IV access, intranasal (IN) and intramuscular (IM) routes are preferred for naloxone administration. Intranasal naloxone (Narcan spray) is the simplest—insert the nozzle into one nostril and press the plunger. IM naloxone (auto-injector like Evzio, or naloxone vial with needle) can be given in the outer thigh even through clothing. Onset is 2-5 minutes for IM/IN versus 1-2 minutes for IV. IV is the fastest-acting route and preferred in clinical settings. Intraosseous (IO) is used when IV access is unavailable in clinical settings. Oral naloxone is not appropriate for acute overdose as absorption is too slow and first-pass metabolism reduces bioavailability.

Question 7: What is the 'Evzio' auto-injector in the context of opioid overdose response?

An electronic monitoring device for opioid overdose detection
An FDA-approved naloxone auto-injector that provides voice instructions to guide lay users through administration (Correct answer)
A newer opioid medication for pain management
A naloxone tablet for oral administration

Correct answer: An FDA-approved naloxone auto-injector that provides voice instructions to guide lay users through administration

Evzio is an FDA-approved naloxone auto-injector designed for community use, providing step-by-step electronic voice instructions during administration.

Evzio is an FDA-approved naloxone auto-injector designed specifically for use by lay bystanders and family members of individuals at risk for opioid overdose. Key features include: (1) Electronic voice guidance that gives step-by-step instructions ('Remove red safety guard, place black end against outer thigh...'), (2) Simple auto-injection mechanism (similar to epinephrine auto-injectors), (3) Available in 0.4 mg and 2 mg doses, (4) Can be administered through clothing, (5) Compact, easily carried device. Along with Narcan nasal spray, Evzio has greatly expanded access to naloxone for community overdose response. Both devices are available in many states without a prescription, and many harm reduction programs distribute them free of charge.

Question 8: Why might multiple doses of naloxone be required when treating a fentanyl overdose compared to a heroin overdose?

Fentanyl is a less potent opioid requiring more medication to reverse
Fentanyl and its analogs are significantly more potent than heroin, binding mu-opioid receptors with much higher affinity, requiring larger or repeated naloxone doses to displace (Correct answer)
Fentanyl does not cause respiratory depression
Naloxone does not work for fentanyl overdose

Correct answer: Fentanyl and its analogs are significantly more potent than heroin, binding mu-opioid receptors with much higher affinity, requiring larger or repeated naloxone doses to displace

Fentanyl's extremely high receptor affinity (50-100x more potent than morphine) means more naloxone may be needed to competitively displace it from receptors.

Fentanyl is approximately 50-100 times more potent than morphine and 50 times more potent than heroin. Illicitly manufactured fentanyl (IMF) and its analogs (carfentanil, acetylfentanyl, etc.) have flooded the drug supply and are responsible for the majority of opioid overdose deaths. Their extremely high mu-opioid receptor affinity and potency mean that standard naloxone doses (0.4-2 mg) may be insufficient to fully displace fentanyl from receptors. Clinical experience during the fentanyl epidemic has shown that many patients require 4-8 mg or more of naloxone. This is why higher-dose formulations (4 mg nasal spray) and multiple-dose protocols were developed. Carfentanil (10,000x more potent than morphine) may require even higher naloxone doses.

Question 9: What should a bystander do if a suspected opioid overdose victim begins to vomit after naloxone administration?

Continue rescue breathing regardless of vomiting
Roll the person into the recovery position (on their side) immediately to prevent aspiration (Correct answer)
Administer more naloxone
Perform abdominal thrusts

Correct answer: Roll the person into the recovery position (on their side) immediately to prevent aspiration

Place the person in the recovery position (on their side) to prevent aspiration of vomit into the lungs, a potentially fatal complication.

Vomiting is common during opioid overdose and after naloxone administration (particularly if the person has been lying on their back). An unconscious or semi-conscious person who vomits while supine is at high risk of aspiration—inhalation of stomach contents into the lungs, which can cause aspiration pneumonia or sudden airway obstruction and death. The recovery position (lateral decubitus position: person on their side with the airway open) uses gravity to allow vomit to drain from the mouth rather than into the airway. If the person is breathing, placing them in the recovery position is appropriate. If they are not breathing, rescue breathing must be the priority—but if vomiting begins during rescue breathing, turn them temporarily to clear the airway.

Question 10: Does administering naloxone to a non-opioid-dependent person who has overdosed on opioids cause withdrawal symptoms?

Yes, naloxone always causes withdrawal regardless of dependence
No, withdrawal symptoms from naloxone only occur in opioid-dependent individuals; non-dependent people simply wake up and recover (Correct answer)
Yes, naloxone causes seizures in everyone who receives it
No, naloxone has no side effects of any kind

Correct answer: No, withdrawal symptoms from naloxone only occur in opioid-dependent individuals; non-dependent people simply wake up and recover

Opioid withdrawal syndrome from naloxone only occurs in physically opioid-dependent individuals; non-dependent people experience simple reversal of overdose effects.

Naloxone-precipitated withdrawal syndrome occurs only in opioid-dependent individuals whose receptors have adapted to chronic opioid presence. In these individuals, rapid displacement of opioids by naloxone causes sudden withdrawal: agitation, nausea, vomiting, muscle cramps, diaphoresis, hypertension, tachycardia, and in severe cases, pulmonary edema or cardiovascular collapse. In non-dependent individuals (e.g., someone who took opioids for pain management without physical dependence, or who took an overdose for the first time), naloxone simply reverses the overdose effects and the person wakes up. In clinical settings, naloxone is often titrated slowly in dependent patients to restore breathing without precipitating full withdrawal.

Question 11: What is the proper disposal method for a used naloxone auto-injector (Evzio) or syringe?

Dispose of in regular household trash
Place in a puncture-resistant sharps container or take to a medication disposal site (Correct answer)
Recap the needle and keep for potential re-use
Flush down the toilet

Correct answer: Place in a puncture-resistant sharps container or take to a medication disposal site

Used needles and auto-injectors must be disposed of in puncture-resistant sharps containers to prevent needle-stick injuries and drug diversion.

Used naloxone syringes, auto-injectors, and any other sharps must be properly disposed of to prevent needle-stick injuries (which can transmit bloodborne pathogens like HIV and hepatitis C) and to prevent medication diversion. Proper disposal options include: (1) Place in a FDA-cleared hard plastic sharps container, (2) Use a household container made of heavy-duty plastic with a screw-on lid as an alternative, (3) Drop-off at a sharps mail-back program, (4) Community sharps collection site or pharmacy take-back program. Many naloxone kits include a sharps container. Never recap used needles using both hands—a single-hand scoop technique or safety cap may be used if necessary before reaching a container.

Question 12: In the context of opioid overdose response, what does the 'Good Samaritan Law' provide in many U.S. states?

It requires everyone to administer naloxone in an overdose emergency
It provides legal protection from drug possession charges for people who call 911 or assist during a drug overdose (Correct answer)
It mandates that pharmacies dispense naloxone without a prescription
It allows EMS to withhold naloxone from repeat overdose patients

Correct answer: It provides legal protection from drug possession charges for people who call 911 or assist during a drug overdose

Good Samaritan laws protect people who call for help during an overdose from prosecution for drug-related offenses, reducing hesitation to seek help.

Good Samaritan laws (also called drug overdose immunity laws or 911 immunity laws) exist in most U.S. states and provide varying degrees of legal protection—typically immunity from prosecution for drug possession, paraphernalia, or intoxication charges—for individuals who call 911 during a drug overdose emergency or assist an overdose victim. Fear of arrest is a major barrier to calling 911 during overdoses, particularly in communities with heavy policing. These laws aim to reduce overdose deaths by encouraging bystanders to seek emergency help without fear of legal consequences. The scope of protection varies by state—some protect only the caller, others also protect the victim. Knowledge of local Good Samaritan laws is an important component of overdose prevention education.

Question 13: What is 'harm reduction' in the context of opioid use and overdose prevention?

A law enforcement approach to drug use
A public health philosophy that aims to reduce negative consequences of drug use through practical strategies without requiring abstinence (Correct answer)
The use of lower-potency opioids as a replacement therapy
A surgical procedure to reduce opioid cravings

Correct answer: A public health philosophy that aims to reduce negative consequences of drug use through practical strategies without requiring abstinence

Harm reduction encompasses pragmatic, evidence-based strategies to reduce drug use-associated harms—including naloxone distribution, syringe programs, and fentanyl test strips.

Harm reduction is a public health approach that acknowledges that some individuals will continue to use drugs and seeks to reduce the negative health, social, and economic consequences associated with drug use without necessarily requiring abstinence. Key harm reduction strategies for opioid use include: (1) Naloxone distribution to people who use drugs and their social networks, (2) Syringe service programs (SSPs) to reduce HIV and hepatitis C transmission, (3) Fentanyl test strips to detect fentanyl contamination in drugs, (4) Medication-assisted treatment (MAT) with methadone or buprenorphine, (5) Supervised consumption sites (in some countries), (6) Education about safer use practices. Evidence consistently shows harm reduction programs save lives and reduce healthcare costs without increasing drug use.

Question 14: What is the difference between opioid tolerance and opioid physical dependence?

They are identical terms meaning the same condition
Tolerance is the need for increasing doses to achieve the same effect; dependence is a physical adaptation where stopping the drug causes withdrawal symptoms (Correct answer)
Tolerance occurs only with illegal opioids; dependence occurs only with prescribed opioids
Dependence always leads to addiction; tolerance does not

Correct answer: Tolerance is the need for increasing doses to achieve the same effect; dependence is a physical adaptation where stopping the drug causes withdrawal symptoms

Tolerance (need for higher doses for same effect) and dependence (withdrawal upon cessation) are distinct pharmacological adaptations that can occur independently.

Opioid tolerance and physical dependence are distinct pharmacological phenomena: Tolerance develops when repeated opioid exposure reduces drug effect, requiring higher doses to achieve the same analgesic or euphoric effect. This occurs through receptor downregulation, uncoupling of receptors from G-proteins, and increased receptor internalization. Physical dependence is a neuroadaptation where the body adjusts to the constant presence of opioids, and abrupt cessation causes a withdrawal syndrome (anxiety, sweating, muscle pain, diarrhea, insomnia, etc.). Both tolerance and dependence can occur in patients taking opioids for legitimate pain management without addiction. Addiction is a distinct disorder characterized by compulsive use despite harmful consequences, which is not synonymous with tolerance or dependence.

Question 15: What is 'medication-assisted treatment' (MAT) for opioid use disorder, and what medications are used?

Short-term pain medication given in the emergency department for withdrawal symptoms only
FDA-approved medications (methadone, buprenorphine, naltrexone) combined with counseling and behavioral therapies to treat opioid use disorder (Correct answer)
Inpatient detoxification without any medications
Administering naloxone daily to prevent opioid use

Correct answer: FDA-approved medications (methadone, buprenorphine, naltrexone) combined with counseling and behavioral therapies to treat opioid use disorder

MAT uses FDA-approved medications (methadone, buprenorphine/Suboxone, naltrexone/Vivitrol) with behavioral support to treat opioid use disorder and reduce overdose risk.

Medication-assisted treatment (MAT), now more often called medications for opioid use disorder (MOUD), combines FDA-approved medications with counseling and psychosocial support to treat opioid use disorder (OUD). The three approved medications are: (1) Methadone (full opioid agonist)—dispensed daily at licensed opioid treatment programs, reduces cravings and prevents withdrawal, (2) Buprenorphine (partial opioid agonist, often combined with naloxone as Suboxone)—can be prescribed in office-based settings, reduces cravings and blocks euphoria, (3) Naltrexone (opioid antagonist, injectable Vivitrol)—blocks opioid effects, requires full detox before use. MAT dramatically reduces opioid overdose deaths, infectious disease transmission, and criminal activity while improving retention in treatment.

Question 16: How should naloxone be administered intramuscularly (IM) in the field by a trained community responder?

Into the buttock only, at a 90° angle
Into the outer thigh or upper arm at a 90° angle, using the auto-injector against the skin or with a syringe and needle, even through clothing if necessary (Correct answer)
Into the arm at a 45° angle using a tuberculin syringe
Into a vein at the inner elbow for fastest absorption

Correct answer: Into the outer thigh or upper arm at a 90° angle, using the auto-injector against the skin or with a syringe and needle, even through clothing if necessary

IM naloxone is given at a 90° angle into the outer thigh or deltoid, even through clothing, using the Evzio auto-injector or a standard IM syringe.

Intramuscular naloxone injection technique for community responders: (1) Remove the safety cap from the auto-injector or draw up the appropriate dose in a syringe, (2) Target the outer thigh (vastus lateralis) or upper outer arm (deltoid), (3) Press firmly against the skin at a 90° angle—clothing does not need to be removed, injection through clothing is acceptable in emergencies, (4) For auto-injectors (Evzio), hold against skin and press the button, (5) For syringe, insert the entire needle at 90°, aspirate briefly, inject, and withdraw, (6) Hold pressure on the site. The onset is 2-5 minutes, slightly slower than IV but appropriate for emergency community use. Needleless devices like Narcan nasal spray are preferred when available as they eliminate needle-stick risk.

Question 17: What is the role of fentanyl test strips in opioid overdose prevention?

They are used by police to test seized drugs for evidence
They allow people who use drugs to test their substances for the presence of fentanyl before use, enabling them to avoid or take precautions with contaminated drugs (Correct answer)
They are prescription devices used only by pharmacists
They detect opioid use in urine samples

Correct answer: They allow people who use drugs to test their substances for the presence of fentanyl before use, enabling them to avoid or take precautions with contaminated drugs

Fentanyl test strips detect fentanyl contamination in illicit drugs, empowering people to make informed decisions and reduce overdose risk.

Fentanyl test strips (FTS) are immunoassay-based lateral flow test strips originally designed for urine drug testing that can be used to detect fentanyl and many of its analogs in illicit drug samples (dissolved in water). Given that illicitly manufactured fentanyl is now found in a wide range of drugs (heroin, cocaine, methamphetamine, counterfeit pills), FTS are a critical harm reduction tool. When a positive test is found, people can choose to avoid the drug, use less, use with someone present, or have naloxone available. Studies show FTS reduce overdose risk behaviors and are acceptable to people who use drugs. Many states have reclassified FTS as legal harm reduction tools rather than drug paraphernalia. They are typically distributed by syringe service programs and harm reduction organizations.

Question 18: What does 'naloxone standing orders' or 'pharmacy standing orders' mean in the context of opioid overdose prevention?

A court order requiring all patients to receive naloxone
A protocol allowing pharmacists to dispense naloxone to individuals without a traditional individual prescription, using a physician or public health officer's blanket order (Correct answer)
An order for healthcare providers to stock naloxone in all rooms
A requirement for all opioid patients to purchase naloxone

Correct answer: A protocol allowing pharmacists to dispense naloxone to individuals without a traditional individual prescription, using a physician or public health officer's blanket order

Standing orders allow pharmacies to dispense naloxone directly to anyone who requests it without an individual prescription, dramatically expanding access.

Naloxone standing orders (also called collaborative practice agreements, protocol orders, or statewide standing orders) are blanket prescriptions issued by a licensed prescriber (physician, public health officer, or state health official) that authorize pharmacists to dispense naloxone to any individual who requests it, without requiring a prescription written for that specific patient. As of 2023, all 50 U.S. states have mechanisms allowing naloxone to be obtained without an individual prescription at pharmacies. Some states have gone further with 'over-the-counter' availability—the FDA approved Narcan 4 mg nasal spray as an over-the-counter medication in March 2023. These policies dramatically expand access to naloxone for at-risk individuals and their families.

Question 19: What are the primary reasons opioids cause respiratory depression at toxic doses?

They directly damage the lungs and cause pneumonia
Opioids bind to mu-receptors in the brainstem respiratory centers (medulla and pons), reducing the sensitivity of chemoreceptors to CO2 and decreasing respiratory drive (Correct answer)
They cause the airway to swell shut
They paralyze the diaphragm muscle permanently

Correct answer: Opioids bind to mu-receptors in the brainstem respiratory centers (medulla and pons), reducing the sensitivity of chemoreceptors to CO2 and decreasing respiratory drive

Opioids suppress brainstem respiratory centers, reducing CO2 chemoreceptor sensitivity and decreasing both rate and depth of breathing.

Opioids cause respiratory depression primarily through action on mu-opioid receptors in the medullary respiratory centers, including the pre-Bötzinger complex (the respiratory rhythm generator), the nucleus tractus solitarius, and peripheral chemoreceptors. Mu-receptor activation reduces the sensitivity of central chemoreceptors to rising CO2 levels (hypercapnia), which is the primary stimulus for breathing. This leads to decreased respiratory rate (bradypnea), reduced tidal volume, and irregular breathing patterns. At toxic doses, apnea (complete cessation of breathing) occurs. Opioids also decrease upper airway muscle tone, contributing to airway obstruction. Secondary hypoxia (from reduced ventilation) then depresses the hypoxic ventilatory response. Death from opioid overdose is due to progressive hypoxia and hypercapnia leading to cardiac arrest.

Question 20: After successfully reversing a suspected opioid overdose with naloxone, what is the most important next step?

Let the person go if they feel better and seem awake
Call or ensure 911 has been called, stay with the person, and transport to the hospital for monitoring and evaluation (Correct answer)
Administer a second dose of naloxone to prevent relapse
Remove any drugs from the scene to prevent further use

Correct answer: Call or ensure 911 has been called, stay with the person, and transport to the hospital for monitoring and evaluation

Always call 911 and ensure hospital transport even after successful reversal—renarcotization is a real risk, and medical evaluation for underlying causes is needed.

Even after apparent successful reversal of opioid overdose with naloxone, it is critical to: (1) Ensure 911 has been called—EMS should evaluate the patient regardless of apparent recovery, (2) Stay with the person—naloxone wears off in 30-90 minutes and renarcotization can cause them to stop breathing again, (3) Ensure hospital transport—medical evaluation is needed to assess: what was taken, what dose, were other drugs involved, does the patient have underlying medical issues, and is MAT/addiction treatment appropriate, (4) Place in recovery position if semi-conscious to protect airway, (5) Be prepared to administer additional naloxone if the person becomes unresponsive again. Many communities advise against leaving the person alone for at least 1-2 hours. Harm reduction programs also use this contact as an opportunity to offer treatment resources.

Question 21: What is the mechanism of synthetic opioids like fentanyl causing 'wooden chest syndrome,' and how does it affect resuscitation?

Fentanyl deposits in chest muscles making them stiff
Rapid high-dose fentanyl administration causes rigidity of the chest and abdominal muscles via CNS mechanisms, making ventilation extremely difficult (Correct answer)
Fentanyl causes the sternum to fuse to the ribs
Wooden chest is caused by fentanyl allergy

Correct answer: Rapid high-dose fentanyl administration causes rigidity of the chest and abdominal muscles via CNS mechanisms, making ventilation extremely difficult

Fentanyl at high doses causes centrally-mediated muscle rigidity affecting the chest wall and abdomen, making bag-mask ventilation extremely difficult.

Wooden chest syndrome (also called opioid-induced rigidity or chest wall rigidity) is a rare but life-threatening complication of rapid administration of high-dose synthetic opioids, particularly fentanyl and sufentanil. The mechanism involves mu-opioid receptor activation in the basal ganglia and other CNS areas, causing generalized muscle rigidity affecting the chest and abdominal wall muscles. This makes the chest nearly impossible to ventilate with bag-mask or even with endotracheal tube ventilation because the stiffened chest walls resist inflation. Management includes: (1) High-dose naloxone (which may reverse the rigidity), (2) Neuromuscular blocking agents (succinylcholine) to relax muscles for intubation, (3) If neither is available, very high pressure ventilation may force air through. This complication is increasingly relevant as illicitly manufactured fentanyl becomes more prevalent.

Question 22: Why is it important for a bystander to call 911 BEFORE administering naloxone in a suspected opioid overdose?

EMS must authorize naloxone use before bystanders can give it
Calling 911 activates professional medical support; the operator can provide instructions and EMS arrives to manage potential complications, renarcotization, and other medical needs (Correct answer)
Naloxone cannot be given without a witness from 911
Police need to be called before any medical treatment

Correct answer: Calling 911 activates professional medical support; the operator can provide instructions and EMS arrives to manage potential complications, renarcotization, and other medical needs

Calling 911 first ensures professional medical backup is en route; the 911 operator can also guide the caller through naloxone administration and CPR if needed.

Calling 911 should happen simultaneously with or before naloxone administration for several reasons: (1) Professional medical support is needed for potential complications, IV access, cardiac monitoring, and hospital transport, (2) 911 operators can provide real-time guidance for naloxone administration and CPR, (3) EMS can administer higher doses, establish IV access, and manage renarcotization, (4) Medical evaluation is needed even after successful reversal, (5) In cardiac arrest (not just respiratory depression), EMS with ACLS capability is essential, (6) EMS can connect the patient to addiction treatment resources. Many 911 systems are equipped to provide 'mobile integrated healthcare' responses that include addiction treatment referrals. Good Samaritan laws protect callers from legal consequences in most states.

Question 23: What is the significance of 'co-occurring substance use' in opioid overdose presentations?

It means the patient is using two different brands of opioids
Mixing opioids with other CNS depressants (benzodiazepines, alcohol, barbiturates) dramatically increases overdose risk and may reduce naloxone effectiveness for reversing all symptoms (Correct answer)
Co-occurring use only applies to illegal drug combinations
It has no clinical significance in overdose management

Correct answer: Mixing opioids with other CNS depressants (benzodiazepines, alcohol, barbiturates) dramatically increases overdose risk and may reduce naloxone effectiveness for reversing all symptoms

Polydrug use with CNS depressants like benzodiazepines and alcohol multiplies overdose risk and may require additional interventions beyond naloxone.

Opioid overdose frequently involves co-occurring substances, most importantly CNS depressants. The combination of opioids with benzodiazepines (the most dangerous combination), alcohol, barbiturates, muscle relaxants, or gabapentinoids creates additive or synergistic CNS and respiratory depression, greatly increasing overdose risk and mortality. A 2017 FDA black box warning highlights this risk specifically for opioid-benzodiazepine combinations. Clinically, this matters because naloxone only reverses opioid effects—if the patient has significant benzodiazepine or alcohol intoxication, they may remain unresponsive or have respiratory depression even after full opioid reversal with naloxone. In these cases, supportive care (airway management, mechanical ventilation) is needed until the co-intoxicant is metabolized. Flumazenil (benzodiazepine antagonist) can reverse benzodiazepine effects but has significant risks.

Question 24: What is the significance of 'opioid-related respiratory depression' occurring during the first 15-30 minutes of IV opioid administration in a healthcare setting?

It only occurs in patients without tolerance
It represents the peak risk window when plasma concentration is highest, particularly when opioids are rapidly administered IV, and monitoring is essential (Correct answer)
Respiratory depression after IV opioids is always benign and self-limited
IV opioids cannot cause respiratory depression

Correct answer: It represents the peak risk window when plasma concentration is highest, particularly when opioids are rapidly administered IV, and monitoring is essential

The period immediately after IV opioid administration carries the highest respiratory depression risk as plasma levels peak, requiring close monitoring.

In healthcare settings, the highest risk of opioid-induced respiratory depression (OIRD) occurs in the first 15-30 minutes after IV opioid administration when plasma concentration is at its peak. Risk is amplified by: rapid IV bolus administration, large doses, opioid-naive patients, elderly patients, sleep apnea, other CNS depressants, and post-operative states. Monitoring standards for patients receiving IV opioids typically include continuous pulse oximetry and respiratory rate monitoring in the post-anesthesia care unit (PACU) and during patient-controlled analgesia (PCA). The Joint Commission (TJC) and anesthesia societies have guidelines requiring continuous monitoring for patients receiving parenteral opioids. Healthcare-associated opioid overdose (occurring in hospitals) represents a significant but under-recognized problem.

Question 25: What is buprenorphine, and how does it differ from methadone in treating opioid use disorder?

They are identical treatments with no clinical differences
Buprenorphine is a partial opioid agonist with a ceiling effect on respiratory depression that can be prescribed by office-based providers; methadone is a full agonist requiring dispensing at licensed clinics (Correct answer)
Buprenorphine is stronger than methadone
Methadone is safer than buprenorphine for overdose risk

Correct answer: Buprenorphine is a partial opioid agonist with a ceiling effect on respiratory depression that can be prescribed by office-based providers; methadone is a full agonist requiring dispensing at licensed clinics

Buprenorphine's partial agonist ceiling effect makes it safer in overdose; it can be prescribed in office-based settings, improving accessibility compared to methadone clinics.

Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) are partial mu-opioid receptor agonists used for medication for opioid use disorder (MOUD). Key differences from methadone: (1) Partial agonism creates a ceiling effect—above certain doses, increasing buprenorphine does not further increase respiratory depression, making it inherently safer in overdose, (2) Buprenorphine can be prescribed by DATA 2000-waivered physicians, nurse practitioners, and PAs in office-based settings (DATA Act 2023 eliminated the waiver requirement in the US), while methadone for OUD must be dispensed daily at licensed opioid treatment programs (OTPs), (3) Take-home doses of buprenorphine can be provided from day one (flexibility), while methadone take-home doses require demonstrated stability, (4) Both are highly effective—methadone may have slight advantages in retention for those with very high tolerance.

Question 26: What physiological changes occur during opioid withdrawal, and are they life-threatening?

Withdrawal causes severe bradycardia and is typically fatal without treatment
Withdrawal causes sympathetic hyperactivation (tachycardia, hypertension, diaphoresis, diarrhea, muscle aches, anxiety) that is extremely uncomfortable but rarely life-threatening in healthy adults (Correct answer)
Withdrawal only causes mild discomfort
Opioid withdrawal causes seizures in all patients

Correct answer: Withdrawal causes sympathetic hyperactivation (tachycardia, hypertension, diaphoresis, diarrhea, muscle aches, anxiety) that is extremely uncomfortable but rarely life-threatening in healthy adults

Opioid withdrawal is an extremely uncomfortable sympathetic storm but is rarely fatal in otherwise healthy adults, unlike alcohol or benzodiazepine withdrawal.

Opioid withdrawal is a syndrome of profound sympathetic nervous system activation following opioid cessation or precipitated by naloxone in dependent individuals. Symptoms progress in stages: (1) Early (6-24 hours post-cessation): anxiety, agitation, yawning, lacrimation, rhinorrhea, diaphoresis, (2) Intermediate (24-72 hours): muscle aches, hot/cold flashes, nausea, vomiting, insomnia, (3) Peak (48-96 hours): severe GI cramping, profuse diarrhea, tremors, tachycardia, hypertension, piloerection, (4) Gradual resolution (1-2 weeks). While intensely uncomfortable—described as 'severe flu'—opioid withdrawal is rarely fatal in otherwise healthy adults. Exceptions: dehydration from vomiting/diarrhea can be dangerous in elderly, young children, or those with heart disease; withdrawal in neonatal abstinence syndrome requires careful management. This contrasts with alcohol and benzodiazepine withdrawal, which carry significant mortality risk from seizures and delirium tremens.

Question 27: What is the recommended approach when administering naloxone to a pregnant woman with opioid overdose?

Naloxone is contraindicated in pregnancy
Administer naloxone immediately to save the mother's life—the risk of maternal death from overdose outweighs concerns about precipitating fetal withdrawal (Correct answer)
Only use half the normal dose to protect the fetus
Wait for obstetric consultation before giving naloxone

Correct answer: Administer naloxone immediately to save the mother's life—the risk of maternal death from overdose outweighs concerns about precipitating fetal withdrawal

Maternal opioid overdose is a life-threatening emergency—administer naloxone immediately; the risk of maternal death far outweighs the risk of fetal withdrawal.

When a pregnant woman presents with opioid overdose, naloxone should be administered immediately without delay. The reasoning: (1) Maternal death from respiratory arrest eliminates any chance of fetal survival, (2) Severe maternal hypoxia causes fetal hypoxia and potential death or brain damage, (3) The risk of precipitating fetal withdrawal (which can be uncomfortable and require management but is manageable) is far less than the risk of maternal death, (4) Naloxone may precipitate uterine contractions and in the third trimester could theoretically trigger preterm labor—but this concern must not delay treatment in a life-threatening emergency. Standard doses and routes are used. After maternal stabilization, fetal monitoring and obstetric evaluation are required. All pregnant women who receive naloxone need hospital-level monitoring given the potential for renarcotization and fetal monitoring needs.

Question 28: What is the clinical significance of 'opioid-induced constipation' (OIC) and how does it differ from opioid tolerance for pain relief?

OIC develops alongside pain tolerance and resolves when pain tolerance develops
OIC develops at the same time as pain relief but does not develop tolerance like analgesia does, often persisting throughout opioid therapy (Correct answer)
OIC only occurs with oral opioids
OIC is easily treated by increasing opioid dose

Correct answer: OIC develops at the same time as pain relief but does not develop tolerance like analgesia does, often persisting throughout opioid therapy

Opioid analgesia develops tolerance over time but GI effects (constipation) typically persist throughout therapy as enteric opioid receptors don't develop tolerance the same way.

This is an important pharmacological distinction: opioid receptors in the central nervous system (CNS) develop significant tolerance to analgesic, sedating, and euphoric effects over time—requiring dose escalation for the same effect. However, opioid receptors in the enteric nervous system (gut) develop much less tolerance to the effects of opioids on gut motility. This means that while patients may need increasing opioid doses for pain relief, constipation (from decreased gut motility), delayed gastric emptying, and nausea often persist throughout the entire course of therapy. Opioid-induced constipation affects 40-80% of patients on chronic opioids and significantly impacts quality of life. Management includes: increased fluid/fiber intake, stimulant laxatives (not stool softeners alone), and peripherally acting mu-opioid receptor antagonists (PAMORAs) like methylnaltrexone and naloxegol that act in the gut without crossing the blood-brain barrier.

Question 29: What does the term 'opioid use disorder' (OUD) mean clinically, and how is it diagnosed?

OUD is simply having a tolerance to opioids from medical use
OUD is a chronic, relapsing brain disorder characterized by compulsive opioid use despite harmful consequences, diagnosed by meeting ≥2 of 11 DSM-5 criteria over 12 months (Correct answer)
OUD only applies to illegal opioid use
OUD is diagnosed only when someone has overdosed

Correct answer: OUD is a chronic, relapsing brain disorder characterized by compulsive opioid use despite harmful consequences, diagnosed by meeting ≥2 of 11 DSM-5 criteria over 12 months

OUD is a DSM-5 diagnosis requiring ≥2 of 11 criteria over 12 months—criteria include compulsive use, loss of control, cravings, and continued use despite negative consequences.

Opioid Use Disorder (OUD) is a DSM-5 diagnosis of a problematic pattern of opioid use causing significant clinical impairment. Diagnosis requires meeting ≥2 of 11 criteria within 12 months: (1) Taking more opioids/longer than intended, (2) Unsuccessful efforts to cut down, (3) Much time spent obtaining/using/recovering, (4) Craving, (5) Failure to fulfill role obligations, (6) Continued use despite interpersonal problems, (7) Giving up activities for opioid use, (8) Recurrent use in hazardous situations, (9) Continued use despite health consequences, (10) Tolerance, (11) Withdrawal. Severity: mild (2-3 criteria), moderate (4-5), severe (≥6). Importantly, criteria 10 and 11 (tolerance and withdrawal) do not count toward the diagnosis in patients taking opioids solely as prescribed. OUD can develop from prescription opioids, not just illicit drug use.

Question 30: What is the mechanism by which naloxone is administered via the intranasal route and what factors affect its absorption?

Intranasal naloxone is absorbed through the nasal mucosa directly into systemic circulation, bypassing first-pass metabolism (Correct answer)
Intranasal naloxone enters the CSF directly through the cribriform plate
Intranasal absorption is identical to oral absorption
Nasal administration converts naloxone to a more potent form

Correct answer: Intranasal naloxone is absorbed through the nasal mucosa directly into systemic circulation, bypassing first-pass metabolism

Intranasal naloxone is absorbed through the richly vascular nasal mucosa into systemic circulation, providing bioavailability of ~50% with onset in 2-5 minutes.

Intranasal (IN) naloxone is absorbed through the highly vascular nasal mucosa (especially the posterior turbinates supplied by the sphenopalatine artery) directly into systemic circulation, bypassing the gastrointestinal tract and first-pass hepatic metabolism. Bioavailability is approximately 40-50% (compared to ~100% for IV). Factors affecting IN absorption: (1) Volume—smaller volumes (≤0.5 mL per nostril) are absorbed more efficiently than large volumes that drip into the throat, (2) Concentration—higher concentration formulations (4 mg/0.1 mL Narcan spray) deliver more drug per volume, (3) Nasal congestion—congested mucosa may reduce absorption and rate, (4) Mucosal condition—trauma, rhinitis, or excessive secretions impair absorption. Onset is 2-5 minutes for IN versus 1-2 minutes for IV. The 4 mg Narcan spray was specifically formulated at high concentration to deliver maximal dose in 0.1 mL for optimal nasal absorption.

Question 31: What is 'prescription drug monitoring program' (PDMP) and its role in preventing opioid misuse?

A program that limits prescription opioid manufacturing
A state electronic database that tracks controlled substance prescriptions, allowing prescribers and pharmacists to identify patients receiving excessive prescriptions or high-risk patterns (Correct answer)
A federal law requiring all opioid prescriptions to be written on paper
A program that monitors patients taking opioids for signs of misuse

Correct answer: A state electronic database that tracks controlled substance prescriptions, allowing prescribers and pharmacists to identify patients receiving excessive prescriptions or high-risk patterns

PDMPs are state databases tracking controlled substance prescriptions, helping prescribers identify doctor shopping, dangerous drug combinations, and high-risk prescribing patterns.

Prescription Drug Monitoring Programs (PDMPs) are state-run electronic databases that collect, monitor, and analyze data on controlled substance prescriptions. Key functions: (1) Allow prescribers and pharmacists to query patient prescription history before prescribing—identifying 'doctor shopping' (obtaining multiple opioid prescriptions from multiple providers), (2) Alert providers to potentially dangerous drug combinations (opioid + benzodiazepine), (3) Identify unusually high dosing patterns, (4) Enable pharmacists to flag suspicious prescriptions, (5) Generate population-level data for public health surveillance. As of 2023, 49 states have PDMPs. Research shows PDMP use is associated with reductions in opioid prescribing, doctor shopping, and opioid-involved overdose deaths. Mandatory PDMP consultation before prescribing opioids is required in most states. Interstate data sharing (PMP InterConnect) allows queries across state lines.

Question 32: Why is naloxone described as a 'competitive antagonist' rather than an irreversible antagonist?

Naloxone permanently destroys opioid receptors
Naloxone binds reversibly to opioid receptors and can be displaced by higher concentrations of opioids or naturally metabolized off the receptor—hence 'competitive' binding (Correct answer)
Naloxone never leaves the receptor once bound
Naloxone only blocks some subtypes of opioid receptors permanently

Correct answer: Naloxone binds reversibly to opioid receptors and can be displaced by higher concentrations of opioids or naturally metabolized off the receptor—hence 'competitive' binding

Naloxone's competitive antagonism means its effect is overcome if opioid concentration exceeds naloxone concentration—explaining why multiple doses or infusions are sometimes needed.

Naloxone is a competitive antagonist at opioid receptors—it competes with opioids for the same binding site (primarily mu-opioid receptors) through reversible binding. This has several clinical implications: (1) Renarcotization—as naloxone is metabolized and its plasma concentration falls, remaining opioid molecules can rebind receptors, reversing the reversal effect, (2) High-dose opioid overdose may require higher naloxone doses or continuous infusion to maintain adequate receptor occupancy, (3) Very high-affinity opioids (carfentanil, certain fentanyl analogs) may require much larger naloxone doses to effectively compete for receptors, (4) The reversibility means naloxone won't cause permanent receptor blockade—receptor function returns to normal as naloxone is metabolized. This differentiates naloxone from naltrexone, which is also a competitive antagonist but has much longer duration of action.

Question 33: What is the recommended observation period after administering naloxone for opioid overdose before determining the patient is safe to leave without medical care?

15 minutes if the patient appears awake
1-2 hours in a monitored setting due to renarcotization risk, with hospital admission recommended for all opioid overdose patients (Correct answer)
30 minutes at the scene with a bystander
Observation is only needed if a second dose was required

Correct answer: 1-2 hours in a monitored setting due to renarcotization risk, with hospital admission recommended for all opioid overdose patients

The risk of renarcotization (especially with long-acting or high-dose opioids) requires at minimum 1-2 hours of monitoring; hospital admission is strongly recommended.

The appropriate observation period after naloxone administration for opioid overdose is context-dependent: (1) In emergency departments and hospitals, patients should be observed for at minimum 1-2 hours after last naloxone dose, with duration adjusted for opioid type and dose—long-acting opioids (methadone, extended-release formulations) require 12-24+ hours of observation, (2) For short-acting opioids (heroin), 1-4 hours may be sufficient if no further doses required, (3) In out-of-hospital settings, all patients who receive naloxone should be transported to the hospital—no patient should be left without medical oversight, (4) Patients who refuse transport should be educated about renarcotization risk, given a second naloxone dose to keep, and ideally have a trusted person remain with them. The clinical principle: naloxone duration (30-90 min) is shorter than most opioids, making continued monitoring essential.

Question 34: What is 'fentanyl test strip positive' notification and its harm reduction significance?

Notification that law enforcement has detected fentanyl nearby
A positive test strip result indicating fentanyl is present in a drug sample, prompting harm reduction behaviors like using with a buddy, having naloxone ready, or not using the substance (Correct answer)
A laboratory result from a blood test
A notification that a prescriber has tested positive for opioid diversion

Correct answer: A positive test strip result indicating fentanyl is present in a drug sample, prompting harm reduction behaviors like using with a buddy, having naloxone ready, or not using the substance

A positive fentanyl test strip allows people who use drugs to make informed decisions about risk and take protective measures before using a substance.

When a fentanyl test strip (FTS) returns a positive result (indicating fentanyl or some analogs are present in the tested substance), this notification provides critical information that can prompt harm reduction behaviors. Research on FTS use shows that people who receive positive results are significantly more likely to: use smaller amounts to test potency ('go slow'), use with another person present who can administer naloxone, have naloxone immediately accessible, take breaks between uses, change their mind about using at all, and avoid mixing with other substances. Studies (harm reduction studies in multiple cities) demonstrate 50-60% of people change their behavior after a positive result. Some research shows FTS distribution is associated with reduced overdose rates. Limitations include: FTS detects fentanyl but may miss some analogs, uneven mixing ('hot spots') in pressed pills means a negative FTS doesn't guarantee no fentanyl throughout.

Question 35: What is the public health significance of the opioid epidemic's 'three waves'?

Three waves of naloxone versions were released over 30 years
Wave 1 involved prescription opioids (1990s-2000s), Wave 2 heroin (2010-2013), and Wave 3 synthetic opioids/fentanyl (2013-present), each driving overdose death increases with different dominant substances (Correct answer)
Three separate opioid epidemics occurred in three different U.S. regions
The three waves describe the development of three MAT medications

Correct answer: Wave 1 involved prescription opioids (1990s-2000s), Wave 2 heroin (2010-2013), and Wave 3 synthetic opioids/fentanyl (2013-present), each driving overdose death increases with different dominant substances

The three-wave model describes the evolution of the opioid crisis: prescription opioids → heroin → fentanyl/synthetics, each with increasing overdose lethality.

The CDC describes the U.S. opioid crisis in three waves: (1) Wave 1 (1990s): Rise in prescription opioid overdose deaths, driven by aggressive prescribing following OxyContin's 1996 launch, pain advocacy movements, and pharmaceutical marketing downplaying addiction risk. Deaths rose steadily through the 2000s. (2) Wave 2 (began ~2010): Heroin overdose surge. Prescription opioid crackdowns (PDMP expansion, reformulated OxyContin) drove users to cheaper, more available heroin. Mexican trafficking organizations expanded heroin supply. (3) Wave 3 (began ~2013): Illicitly manufactured fentanyl (IMF) and fentanyl analogs flooded the drug supply, first in heroin then in other drugs (cocaine, methamphetamine, counterfeit pills). IMF is 50-100x more potent than morphine—dramatically increasing overdose lethality. By 2021, synthetic opioids accounted for >80% of opioid overdose deaths. A potential Wave 4 involving xylazine (a veterinary tranquilizer) contaminating fentanyl supply is emerging.

Question 36: What is 'intranasal naloxone co-prescription' and why is it recommended for patients on chronic opioid therapy?

Prescribing naloxone only for patients with a known history of overdose
Prescribing naloxone alongside opioids to patients and their household members to enable rapid overdose reversal at home before EMS arrival (Correct answer)
Intranasal naloxone replaces methadone for OUD treatment
Co-prescription is only for patients on ≥200 MME/day

Correct answer: Prescribing naloxone alongside opioids to patients and their household members to enable rapid overdose reversal at home before EMS arrival

Co-prescribing naloxone with opioids to at-risk patients and their caregivers creates immediate overdose reversal capacity in the home setting where most opioid overdoses occur.

Co-prescribing naloxone alongside opioid prescriptions is increasingly recommended and mandated by guidelines and some state laws for patients at elevated overdose risk. This includes patients receiving: ≥50 MME/day, opioids + benzodiazepines or other CNS depressants, patients with history of overdose, substance use disorder, or recent release from incarceration or controlled environments. The rationale: most opioid overdoses occur at home, often witnessed by a family member—having naloxone immediately available enables treatment in minutes rather than the typical EMS response time of 7-10 minutes. States including California, New York, and others have enacted co-prescribing laws requiring naloxone prescriptions with high-dose opioids. Patient and caregiver education on recognition of overdose signs and naloxone administration is essential alongside the prescription.

CPR Opioid Overdose Response and Naloxone 1

What are the three classic signs of opioid overdose, known as the 'opioid overdose triad'?

🃏 CPR Flashcards — Study This Quiz as Flip Cards →

📚 Want to go deeper? Read the Full CPR Study Guide →